Ceva Animal Health has launched Feliway Help!, a new product formulated to help cats during temporary stressful situations, such as a visit to the vet, having guests to stay or holding a party. 

Feliway Help! comes as a starter pack with a pheromone cartridge which lasts seven days and covers 50m2.

The cartridge is inserted into a diffuser which is plugged into an electrical socket, two days before the stressful event. 

Ceva says that 83% of cat owners saw an improvement in their cat’s signs of stress after using Feliway Help!¹. 

The company adds that the Feliway Help! is particularly useful for clients of those practices which Feliway on the premises, with Feliway helping keep the cat calm at the practice, and Feliway Help! taking over when they return home. 

Sarah Heath BVSc PgCertVE DipECAWBM(BM) CCAB FRCVS, an RCVS and EBVS European Veterinary Specialist in Behavioural Medicine and Certified Clinical Animal Behaviourist, said: “Cats can find the veterinary visit challenging and when they go home they can sometimes find it hard to settle.

"Feliway Help! can be very beneficial in easing the transition between home and the practice. 

"This can be particularly helpful when cats have had a stay in hospital.”

For more information, visit www.feliway.com/uk, call the Ceva Animal Health head office on 01494 781510 or email cevauk@ceva.com.

Reference

1. Data on file – 300 cats after seven days of use

Following a two-year postponed judgment, the Disciplinary Committee (DC) of the Royal College of Veterinary Surgeons last week warned a Cambridgeshire veterinary surgeon as to his future conduct, after he had been convicted in 2006 for causing death by careless driving whilst under the influence of alcohol.

In September 2007, the Committee heard that Peter Hanlon MRCVS, of Soham in Cambridgeshire, had been involved in a road traffic accident in February 2006. Mr Hanlon's car had drifted across the road and collided with an oncoming car driven by James Barber who was accompanied by his wife, Ivy. Mr Barber was pronounced dead at the scene and both Mrs Barber and Mr Hanlon sustained injuries.

At the initial hearing, Mr Hanlon admitted the conviction (for which he had been sentenced to 30 months in prison and received a four-year driving ban) and the charge that it rendered him unfit to practise veterinary surgery. The Committee decided to postpone its judgment for two years on the agreement that Mr Hanlon would undertake to abstain from alcohol and to submit quarterly medical reports and six-monthly CPD (continuing professional development) reports to the Committee chairman.

At the resumed hearing last week, the Committee carefully considered Mr Hanlon's written and oral submissions, and accepted that he had fully complied with these undertakings. He had abstained from alcohol since the day after the accident, produced an "exemplary" CPD record and provided impressive reports from his employers concerning his professional competence.

In addition, Mr Hanlon, who spent around 14 months in prison and remained on licence until July 2009, also reiterated to the Committee his remorse for the death of Mr Barber and respect for his family.

The Committee was mindful of its duty to maintain confidence in the veterinary profession and uphold proper standards of conduct. Whilst it did not consider it necessary to postpone judgment again, it felt that Mr Hanlon should be warned about his future conduct.

Caroline Freedman, chairing the Committee, concluded: "As this case has demonstrated, and as Mr Hanlon himself has fully recognised, abuse of alcohol can lead to far reaching consequences in personal and professional lives and the lives of others."

Mary Fraser MRCVS from Girling and Fraser has launched 'Could, Would, Should' a new initiative to support new grads in developing their decision-making skills. 

Mary (or, to give her her full title, Dr Mary Fraser BVMS PhD CertVD PGCHE FHEA MAcadMEd CBiol FRSB FRSPH FRCVS) focussed on decision-making in practice while studying for her MRes in Clinical Veterinary Research, looking at how vets and owners influence the decision making process. This led her to consider how decision making is taught to students.

As part of the initiative, Mary has launched a new website: www.clinicaldecisions.org, which, together with a supporting blog, is designed to help students and recent graduates examine their decision making in practice, consider how owners influence it, and take forward shared decision making for the benefit of all.

Mary said: "As a student decision making can seem difficult. Working with owners, all of whom have different expectations, can add to those challenges.

"I hope that by bringing that discussion to the fore we can support each other and allow future vets and veterinary nurses to identify their own strengths in supporting owners to make the best decisions for their animals."

Find out more and contribute to the discussion at www.clinicaldecisions.org

Pfizer VPS has launched a 'Pre-Sale Scab Treatment Certificate' so that sheep treated for sheep scab and protected against re-infestation beyond their autumn sale date can be formally certified as such.

A choice of two moxidectin-based treatments are eligible for use, one with 28 days and the other 60 days licensed persistency against the scab mite.

Pfizer VPS vet David Bartram explained that following treatment, the sale date must fall within the persistency window: "The idea is that farmers present their certificate at markets on sale day, then auctioneers announce the scab-protected status during their sales patter. Whether this adds to the sale price will be interesting to find out, but it's sure to be seen as a valuable attribute by buyers who won't need to treat for scab when they arrive home."

Details of the certification process are available from SQPs at animal medicine suppliers. The two eligible treatments are CYDECTIN 1% LA and CYDECTIN 2% LA for sheep.

A new study, published in the latest issue of the Journal of Small Animal Practice (JSAP), found that ultrasound-guided fine-needle cytological biopsies (FNCB) of gastrointestinal masses provided a clinically useful sample in two thirds of cases, particularly when more slides were provided to the cytologist and thicker lesions were sampled.

“Assessment of the clinical usefulness of ultrasound-guided cytological specimens obtained from gastrointestinal lesions in dogs and cats” retrospectively reviewed GI cytological samples obtained by ultrasound-guided FNCB of 25 dogs and 19 cats from a single institution between February 2014 to August 2016.

The aim of the study was to assess factors that may influence the clinical usefulness of submitted cytological samples collected from gastrointestinal lesions by ultrasound-guided percutaneous FNCB. Ultrasound-guided FNCB included a combination of FNI (non-aspiration) and FNA techniques, as the specific technique could not be determined retrospectively.

Clinical records were evaluated to obtain historical data, clinical findings, diagnostic results and patient outcomes. Clinically useful samples were defined as smears with sufficient cell yield and preservation to allow at least a tentative cytological diagnosis of the lesion character or pathological process.

Factors that may have influenced the retrieval of a clinically useful sample were assessed and included lesion location, sonographic lesion thickness, loss of or alteration to intestinal layer conspicuity on ultrasound, and the number of slides submitted to the cytologists. The thickness of lesions was further categorised as either a mass (≥20 mm thickness) or a thickening (<20mm).

Two South African veterinary surgeons working in the UK, Jason Davidson (Companion Care, Derby) and Paul Meiring (Companion Care, Chesterfield), have entered the joBerg2C cycle race to raise awareness of and funds towards combatting the rhino poaching crisis in Africa.

During the race, which runs between Johannesburg and Durban in April 2017, Jason and Paul will cover 900km (559 miles) on their velocipedes.

They're raising money for a charity called Chipembere Rhino Foundation, a charity which works to monitor rhino and curb poaching. According to the charity, there are 20,000 African white rhino and 4,800 African black rhino remaining, which classifies them as ‘near-threatened’ and ‘critically endangered’ respectively. Against that background, poaching levels have reached crisis point, with 2,700 rhinos killed between 2000 and 2013, and a further 1215 in 2014 alone. 

The importance of the charity's work was further highlighted today after news that poachers have shot an African white Rhino for its horn at Thoiry Zoo outside Paris.

Jason said: "We are living in a world where our natural resources, from water and minerals to animals and plants, are becoming increasingly rare and as a result they are highly prized and valuable. Habitat destruction and poaching are two of the greatest risks facing the world's wildlife. Rhinos are being killed for their horns, elephants for their tusks, pangolins for their scales and now even donkeys are being killed for their skins. We only have one planet and we all need to do what we can to protect it."

If you’d like to support Jason and Paul in their efforts, you can do so at http://www.justgiving.com/teams/rhinocycle

87% of cat owners would seek veterinary advice when choosing a supplement for their cat, according to a new survey conducted by supplement manufacturer, Vita Animal Health. 

The survey of 97 cat owners and 156 vets conducted in June last year found that currently only 30% of cat owners give supplements to their cat but 74% would be willing to try them.

The survey also found that whilst 80% of vets thought the main reasons to be hesitant about recommending feline supplements were palatability and the owner’s ability to give products, owners were less concerned about the ease of giving the supplement (53%), and more concerned about the cost (45%) and being unsure of the benefits (39%). 

Tara Evans RVN, head of sales at Vita, said: “It is interesting that the majority of vets believe that practicalities around administering oral supplements is the main drawback to giving these products, whereas only 53% of owners were concerned about this.

"Understanding owner concerns regarding efficacy and price could help vets support more owners to move forward with supplements for their cats.” 

According to the survey, the most frequently used supplements, by both vets and owners are those made to support joints.

Cat owners also showed an interest in giving supplements for general wellness (61%). 

Tara added: “Owners are open to supplementing for general health, as well as more specific health-related issues.”

www.vitaanimalhealth.com 

Animalcare has launched a new broad spectrum fluoroquinolone antimicrobial (Enrofloxacin) which the company says is highly effective in the treatment of a wide range of conditions and easy to inject, with excellent tissue penetration.

Enrocare solution for injection is presented in three strengths: A 25mg/ml (2.5%) injection for dogs, cats and exotic animals including reptiles, small mammals and avian species. The 50mg/ml (5%) injection is licensed for use in cattle, pigs, dogs and cats, whilst the 100mg/ml (10%) injection is licensed for cattle and pigs. In the case of dogs and cats a single daily dose is needed.

Animalcare says it has priced Enrocare competitively. In addition, the range has been launched with three offers: "Buy one get one free on the 50 and 100mg/ml" and "Buy two get one free offer" on the 25mg/ml pack size. These offers will last for four months until the end of September.

In cattle, Enrocare  50mg/ml,  given by the subcutaneous route, is licensed for respiratory disease of bacterial or mycoplasmal origin and the 100mg/ml strength is licenced for both respiratory disease and E.coli mastitis (the latter given by slow intravenous injection). According to Animalcare, its low dose volume makes it particularly suitable for the treatment of respiratory disease in calves. In pigs >25kg Enrocare is licensed for the treatment of the respiratory and alimentary tract diseases of bacterial or mycoplasmal origin and multi-factorial diseases such as atrophic rhinitis and enzootic pneumonia.

Tony Liepman, Animalcare Market Manager said: "The recent successful launch of Cephacare flavour raised Animalcare's profile as a supplier of more up-to-date antibiotics and this is our latest addition which offers excellent efficacy at an attractive price."

The RCVS has completed the sale of its Westminster offices to a private investor for £14m. 

The deal includes an option for the College to lease the building for up to two years to give it time to consider its options for the future, and how they may have changed as a result of the pandemic.

The decision to sell the property was made back in November 2018, when Council decided that the building was rapidly becoming unfit for purpose and the College needed more up-to-date and modern facilities with more room for a growing workforce. The College’s Estates Strategy Project Board was tasked with managing the process, chaired by former RCVS President Barry Johnson.

RCVS Treasurer Susan Dawson said: “Council recognised that this deal realised maximum value for the building, especially considering the impact the pandemic has had on property prices in Central London.

“It also provides a very valuable opportunity to reflect on the changing needs of the organisation and the professions and public it serves, and to consider the requirements and different working patterns of the College staff going forwards.

“It is likely that many staff members will wish to continue to work at home more than they did pre-Covid, so the need for pure desk-space may not be as great as we had planned for the 10-15 years ahead. However, the importance of in-person meetings for collaboration, creativity and the maintenance of good corporate culture is not to be underestimated, so our new requirements are likely to be different to that anticipated back in 2018.”

The College says it expects to welcome limited numbers of staff back to the office in June, to work in a socially distanced way, including virtual or partly-virtual meetings. 

Changes to working patterns over the coming months will also help inform decisions around future remote working policies and the type and size of building that will best suit the future needs of the College and its workforce.

A Royal College of Veterinary Surgeons audit panel is to visit UK veterinary schools to assess how Extra-Mural Studies (EMS) is being carried out, identify good practice and make recommendations for improvement. The exercise is part of a package of measures which aims to improve the way that EMS helps veterinary undergraduates to gain skills and knowledge in a practice environment.

RCVS Council agreed to the implementation of proposals made by a Working Party set up to review the whole EMS process in November 2009. While the EMS system was largely agreed to be valuable and working well, some areas were identified for improvement. Many of the recommendations centred on a better understanding amongst all parties involved - students, practices and vet schools - of the aims and objectives of EMS for the student, and improved communication about expectations and outcomes.

As a first step, the Education Policy and Specialisation Committee has put in place an audit of EMS at the veterinary schools. It has commissioned Dr Barry Johnson, who led the original Working Party, together with practitioners David Black, David Wadsworth and Dr Chris Chesney, to follow through individual cases, talking to the students, practitioners and clinical tutors and EMS co-ordinators at the vet schools, to build a picture of how administration, communication and follow-up is managed.

Barry said: "The objective of the audit is to identify areas of good practice that can be shared, and identify where improvements could be made - it will also promote dialogue between practices and the schools. The exercise will be repeated over the next couple of years to track changes."

The first audit took place at the Royal Veterinary College in February, as part of the full RCVS visitation of the undergraduate degree programme. The EMS audit panel will report its initial findings in June.

The full report and recommendations from the EMS Working Party can be viewed at www.rcvs.org.uk/EMS.

Maggie Fisher MRCVS, the parasitologist and chairman of ESCCAP (European Scientific Counsel Companion Animal Parasites), has highlighted studies which demonstrate an association between the common parasite, Toxocara spp. and human disease, and has called on the profession to help reduce the damaging and widespread effects of this parasite.

Maggie says that many in the profession may not be aware that Toxocara eggs aren't actually infective when they are first passed in an animal's stools, sometimes taking weeks to develop to this stage. Eggs persist long after pet waste has naturally washed away too, so the risk of infection still exists even in environments that appear to be clean and safe. Interestingly, there seems to be only a very loose (and according to some studies, entirely absent) link between owning a pet and an increased risk of human Toxocara infection, suggesting that most infections are acquired from the environment^1,2 . Education of pet owners about responsible pet ownership, including appropriate worming and picking up their dog's waste quickly is essential to reduce this environmental infection risk.

The parasite's larval stages cause disease in humans as they migrate through body tissues, with retinal damage a previously well identified consequence. However, Maggie has identified studies which suggest a whole range of common conditions that may also be attributable to Toxocara infection. One study³ included 425 children displaying signs of a persistent cough and 1600 asymptomatic children as controls. Blood tests confirmed that a statistically significant 32% of the symptomatic group were positive for Toxocara antibodies, compared to just 17% of the asymptomatic control group. What's more, when given a week's course of an appropriate anthelmintic, the vast majority of symptomatic children had a greatly reduced and frequently absent requirement for inhaled corticosteroids to control their symptoms when re-examined by the study team a year later.

Numerous other studies from around the world have shown similar strong associations with asthma, allergies and epilepsy. One nationally representative US study even showed an alarming association with Toxocara infection and reduced cognitive function in children² . Those that were positive for antibodies to the parasite on blood tests (proving prior exposure) scored significantly lower on tests assessing verbal and manual dexterity as well as maths and reading abilities² .

So, what should veterinary staff and SQPs be telling clients? Maggie says you should be advising pet owners to worm pets regularly (at least four times a year) with an effective anthelmintic from an appropriately young age (2 weeks of age for puppies and 3 weeks of age for kittens, because transfer of the parasite to puppies before birth and to kittens via milk is a feature of the parasite lifecycle). Reducing pets' access to raw food and hunting activities can also help. This is in addition to more general recommendations including cooking food well and making sure children wash their hands before eating.

Maggie said: "Vets, nurses and SQPs are perfectly placed to make sure that pet owners are aware of the risks and take precautions to protect themselves and the wider general public."

For further information about effective control of Toxocara and a wide range of other companion animal parasites, visit www.esccapuk.org.uk. To view all the presentations from the 'Everyday Parasites' CPD day, visit www.esccapuk-cpd.co.uk.

References:

1. Taylor, M.R., 2006. Ocular Toxocariasis. In: Toxocara, the enigmatic parasite. Holland, C.V., Smith, H.V., Eds. CABI Publishing, Ch. 9, 127-144.
2. 2. 3^rd US National Health and Nutrition Survey Walsh, M.G., 2010. Toxocara infection and diminished lung function in a nationally representative sample from the United Sates population. Int J Parasitol.41(2):243-7
   Walsh, M.G., Haseeb, M.A., 2012. Reduced cognitive function in children with toxocariasis in a nationally representative sample of the United States. Int. J. Parasitol. 42, 1159-1163
3. Bede, O., Szénási, Z., Danka, J., Gyurkovits, K., Nagy, D., 2008. Toxocariasis associated with chronic cough in childhood: a longitudinal study in Hungary. J. Helminthol. 82, 357 - 63.